Our Mission Assistance Case Studies Press Room IPAO Forum
HOME : Kaswan Case Study : FAQs : Kaswan Case Study : Emory Case Study
1  2  3  4  5  6

Emory professors and researchers co-developed two of the major drugs in the HIV/AIDS arsenal: 3TC and FTC. These discoveries are used by approximately 80% of all HIV/AIDS patients who are receiving treatment. These drugs became the subject of litigation and patent disputes during which Emory University went to extraordinary lengths to support their researchers and protect their intellectual property.

Emory financed millions of dollars of legal expenses in support of its academic researchers. In this case the university's involvement is reflected in its results: their intellectual property is intact, their researchers continue happily in their employment, and they have functional, ongoing relationships with their defendants and counterclaimants to facilitate and cultivate continued research that has improved the quality of life for patients both in the U.S. and worldwide.

This case presents an excellent example of what can happen when a university sides with its faculty and researchers.

For More Information on this Case Study

Download the PDF

Also of Interest...

The Two Experimental Uses in Patent Law: Negation and Infringer's Defense

Pharma Giant Tried to Keep UGA Deal Secret

Partnering for Knowledge: A Framework for University-Industry Collaboration

IP Advocate.org Copyright 2019

You are about to leave IPAdvocate.org and go to an outside website.

IPAdvocate.org does not control any outside website and is not responsible

for content, performance or policies, including Privacy Policy.

Thank you for visiting IPAdvocate.org.